These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 29928163)
1. Shortening Treatment for Hepatitis C Virus Infection. Kottilil S Gastroenterol Hepatol (N Y); 2018 Mar; 14(3):186-188. PubMed ID: 29928163 [No Abstract] [Full Text] [Related]
2. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. Piciocchi M; Cardin R; Cillo U; Vitale A; Cappon A; Mescoli C; Guido M; Rugge M; Burra P; Floreani A; Farinati F Transl Res; 2016 Feb; 168():122-133. PubMed ID: 26408804 [TBL] [Abstract][Full Text] [Related]
3. Shortened telomere length in hepatocellular carcinomas and corresponding background liver tissues of patients infected with hepatitis virus. Ohashi K; Tsutsumi M; Kobitsu K; Fukuda T; Tsujiuchi T; Okajima E; Ko S; Nakajima Y; Nakano H; Konishi Y Jpn J Cancer Res; 1996 May; 87(5):419-22. PubMed ID: 8641975 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B and C virus infections in the immune compromised. Haydon GH; Mutimer DJ Curr Opin Infect Dis; 2003 Oct; 16(5):473-9. PubMed ID: 14502001 [TBL] [Abstract][Full Text] [Related]
6. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Vallisa D; Bertè R; Rocca A; Civardi G; Giangregorio F; Ferrari B; Sbolli G; Cavanna L Am J Med; 1999 May; 106(5):556-60. PubMed ID: 10335728 [TBL] [Abstract][Full Text] [Related]
7. Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis. Kwo PY; Puenpatom A; Zhang Z; Hui SL; Kelley AA; Muschi D PLoS One; 2019; 14(8):e0218759. PubMed ID: 31437170 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection: Review and implications for the dentist. Lodi G; Porter SR; Scully C Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jul; 86(1):8-22. PubMed ID: 9690239 [TBL] [Abstract][Full Text] [Related]
9. MiR-122 in hepatitis B virus and hepatitis C virus dual infection. Song K; Han C; Dash S; Balart LA; Wu T World J Hepatol; 2015 Mar; 7(3):498-506. PubMed ID: 25848473 [TBL] [Abstract][Full Text] [Related]
10. New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication. De Mitri MS; Cassini R; Morsica G; Bagaglio S; Zoli M; Bernardi M Dig Liver Dis; 2001 Oct; 33(7):591-4. PubMed ID: 11816550 [TBL] [Abstract][Full Text] [Related]
11. The impact of hepatitis C virus infection on methadone maintenance treatment. Novick DM Mt Sinai J Med; 2000; 67(5-6):437-43. PubMed ID: 11064495 [TBL] [Abstract][Full Text] [Related]
12. Natural history of hepatitis C following liver transplantation. Rodriguez-Luna H; Douglas DD Curr Opin Infect Dis; 2004 Aug; 17(4):363-71. PubMed ID: 15241083 [TBL] [Abstract][Full Text] [Related]
13. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. Mimms LT; Mosley JW; Hollinger FB; Aach RD; Stevens CE; Cunningham M; Vallari DV; Barbosa LH; Nemo GJ BMJ; 1993 Oct; 307(6912):1095-7. PubMed ID: 8251805 [TBL] [Abstract][Full Text] [Related]
14. Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan. Liu CJ; Kao JH; Lai MY; Chen PJ; Chu JS; Chen W; Chen DS J Gastroenterol Hepatol; 1999 Apr; 14(4):352-7. PubMed ID: 10207785 [TBL] [Abstract][Full Text] [Related]
15. Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients. Slimane SB; Albrecht JK; Fang JW; Goodman Z; Mizokami M; Qian K; Lau JY J Viral Hepat; 2000 Jan; 7(1):51-5. PubMed ID: 10718943 [TBL] [Abstract][Full Text] [Related]
16. GB virus-C/hepatitis G virus infection in a hepatitis C virus endemic village: prevalence in residents with low educational attainment and frequent recovery in females. Cheng PN; Chang TT; Yang MH; Hu SC; Young KC; Wu HL; Jen CM; Ko AW; Lu SC Liver; 2000 Jun; 20(3):222-7. PubMed ID: 10902972 [TBL] [Abstract][Full Text] [Related]
17. [Skin diseases and hepatitis virus C infection]. Poljacki M; Gajinov Z; Ivkov M; Matić M; Golusin Z Med Pregl; 2000; 53(3-4):141-5. PubMed ID: 10965678 [TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis C virus infection among haemodialysis patients. Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116 [TBL] [Abstract][Full Text] [Related]
19. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. Pol S; Fontaine H; Carnot F; Zylberberg H; Berthelot P; Bréchot C; Nalpas B J Hepatol; 1998 Jul; 29(1):12-9. PubMed ID: 9696487 [TBL] [Abstract][Full Text] [Related]
20. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies? Missale G; Cariani E; Ferrari C Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]